Physician profile
Danielle Mooshol
NPI 1689021578
$1,756.75
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2022: $191 · 2023: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $387.77 | 2023 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $242.47 | 2023 | Stravix, Grafix Pl, Stravix Pl |
| Triad Life Sciences INC. | $191.31 | 2022 | |
| Organogenesis INC. | $185.63 | 2019-2023 | Puraply |
| Depuy Synthes Sales INC. | $163.13 | 2019 | |
| Orthofix Medical, INC. | $106.26 | 2023 | Physio-Stim, Spinal-Stim |
| Ibsa Pharma INC. | $96.79 | 2023 | Licart |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.36 | 2023 | Jublia |
| Horizon Therapeutics Plc | $62.59 | 2023 | Krystexxa |
| Next Science LLC | $41.88 | 2023 | Xperience, Surgx, Blastx |
| Kerecis Limited | $37.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $32.69 | 2023 | Ortholoc 2 Lapifuse |
| Acell, INC. | $22.01 | 2019 | |
| Kci USA, INC. | $20.71 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $20.67 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $19.22 | 2023 | |
| Zimvie INC. | $17.04 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $12.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mooshol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.